NEW YORK (GenomeWeb News) – Integromics said today that the National Cancer Institute and the ESTools consortium, a European stem cell research organization, have purchased site-wide licenses for its RealTime StatMiner data analysis software solution.
The agreements will enable every researcher based at NCI and ESTools consortium members to use the gene expression software to perform validated bioinformatics analysis of functional gene expression data.
Madrid-based Integromics developed the solution through a partnership with Applied Biosystems.
ESTools Coordinator Peter Andrews said in a statement that the StatMiner software has helped the researchers streamline their data analyses and has given them a way to analyze data from the Applied Biosystems TaqMan Array Cards, and to compare the phenotype of different cell lines against specific standards.
Financial terms of the license agreements were not released.